We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NYSE:NVO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 2.29 | 1.80% | 129.17 | 129.35 | 127.60 | 128.00 | 1,944,849 | 14:58:52 |
From Apr 2019 to Apr 2024
By Dominic Chopping
Danish insulin maker Novo Nordisk A/S (NVO) has signed a memorandum of understanding with the Food and Drug Administration of Iran to build a new manufacturing facility in the country.
The EUR70 million plant will manufacture Novo Nordisk's FlexPen prefilled devices and the project is expected to last five years.
"It signals our long-term commitment to Iran, a country where close to 5 million people have diabetes," said Ole Moelskov Bech, corporate vice president of Novo Nordisk Business Area Near East.
Construction of the new facility will create 160 jobs, it said. Novo Nordisk already employs around 130 people in Iran.
-Write to Dominic Chopping at dominic.chopping@wsj.com; Twitter: @WSJNordics
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
September 22, 2015 04:37 ET (08:37 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
1 Year Novo Nordisk Chart |
1 Month Novo Nordisk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
